Adastra Holdings Ltd. XTXXF
Annual
Quarterly
No annual revenue total was found in ADASTRA HOLDINGS LTD.'s SEC filings.
Adastra Holdings Ltd. (XTXXF) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
55.97M
-15.2% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XTXXF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Langley, British Columbia, Canada
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1891512
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Dec 6, 2023 | Sep 30, 2023 |
| 6-K | Current report (foreign issuer) | Aug 18, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | May 31, 2023 | Mar 31, 2023 |
| 20-F | Annual report (foreign issuer) | May 17, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | May 4, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | May 4, 2023 | May 2, 2023 |
All 41 Adastra Holdings Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.